Zanidatamab dose optimization in patients with HER2-positive biliary tract cancer (BTC) Meeting Abstract
| Authors: | Trueman, S.; Wu, L.; Girgis, S.; Vaidya, K.; Meric-Bernstam, F.; Harding, J. J.; Pant, S.; Zhao, Y.; Garfin, P. M.; Iannone, R.; Zhou, H.; Ma, J. |
| Abstract Title: | Zanidatamab dose optimization in patients with HER2-positive biliary tract cancer (BTC) |
| Meeting Title: | 2025 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2025 Jan 23-25 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-01 |
| DOI: | 10.1200/JCO.2025.43.4_suppl.546 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| DOI/URL: | |
| Notes: | Meeting Abstract: 546 -- Source: CINAHL Plus with Full Text |
